A Study of Abilify® Tablet(Aripiprazole) as an Adjunctive Treatment in the Bipolar Depression

NCT03423680 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

390

Enrollment

INDUSTRY

Sponsor class

Conditions

Depression, Bipolar

Interventions

DRUG: Abilify 2, 5, 10, 15mg (Tablet)
DRUG: Placebo of Abilify 2, 5, 10, 15mg (Tablet)

Sponsor

Korea Otsuka Pharmaceutical Co., Ltd.